Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$34.01 USD
-1.15 (-3.27%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $33.98 -0.03 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LEGN 34.01 -1.15(-3.27%)
Will LEGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LEGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LEGN
Company News for Aug 12, 2025
Key Inflation Data in Focus
LEGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
What Makes Legend Biotech (LEGN) a New Buy Stock
Other News for LEGN
Is LEGN lining up for a decline? Fell Below 20 Day Moving Average shows up after declining 3.27%
Is LEGN building bullish momentum? Crossed Above 20 Day Moving Average shows up after rising 2.0%
20 Day Moving Average Resistance appears for LEGN after 0.38% move
Is LEGN preparing to trend higher? MACD Bullish Signal Line Cross shows up after advancing 1.36%
Stochastic Buy Signal appears for LEGN after 2.33% move